QA: Seelos Therapeutics INC in us_pharma/2011

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001017491_2012_Seelos_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001017491, Seelos Therapeutics INC

  xvar xval
0 AssetsCurrent 8,191,110
1 IntangibleAssetsNetIncludingGoodwill 3,759,950
2 PropertyPlantAndEquipmentNet 4,384,357
3 remainder_Assets 280,193
4 LiabilitiesCurrent 10,020,683
5 LiabilitiesNoncurrent 27,831
6 remainder_Liabilities 1,748,916
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 11,463,448
9 ResearchAndDevelopmentExpense 5,820,763
10 remainder_Expenses 4,996,665
11 remainder_Revenues 4,101,124
12 remainder_NetIncome 62,554
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 16,615,610
1 Liabilities 11,797,430
2 Expenses 22,280,876
3 Revenues 4,101,124
4 StockholdersEquity 4,818,180
5 NetIncome -18,117,198
6 ComprehensiveNetIncome -18,117,198
7 BaseVar 27,428,797
8 EconomicCapitalRatiobeforeLimitedLiability -0.536
9 EconomicCapitalRatio 1.38

Edgar->Model Mapping

Feature Distribution